CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
36.52
-0.62 (-1.67%)
Jul 27, 2026, 3:17 PM EDT - Market open
CareDx Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 412.82 | 379.81 | 333.79 | 280.32 | 321.79 | 296.4 |
Revenue Growth | 19.17% | 13.79% | 19.07% | -12.89% | 8.57% | 54.22% |
Gross Profit Gross Profit Growth | 412.82 | 379.81 | 333.79 | 280.32 | 321.79 | 296.4 |
Operating Income Operating Income Growth | -11.37 | -30.78 | 40.77 | -203.36 | -77.23 | -29.73 |
Net Income Net Income Growth | -8.57 | -21.35 | 52.55 | -190.28 | -76.61 | -30.66 |
Earnings Per Share EPS Growth | -0.16 | -0.40 | 0.93 | -3.54 | -1.44 | -0.59 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States United States Growth | 393.72 | 359.94 | 317.73 | 265.63 | 307.54 | 282.01 |
Rest of World Rest of World Growth | 19.1 | 19.87 | 16.05 | 14.69 | 4.7 | 4.57 |
Total Total Growth | 412.82 | 379.81 | 333.79 | 280.32 | 321.79 | 296.4 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 187.18 | 177.21 | 260.65 | 235.42 | 293.09 | 348.49 |
Total Debt Total Debt Growth | 17.84 | 19.68 | 22.26 | 28.28 | 33.41 | 17.39 |
Net Cash (Debt) Net Cash Growth | 169.34 | 157.53 | 238.39 | 207.14 | 259.68 | 331.09 |
Net Cash Growth | -18.13% | -33.92% | 15.09% | -20.23% | -21.57% | 58.70% |
Net Cash Per Share Net Cash Per Share Growth | 3.19 | 2.96 | 4.21 | 3.85 | 4.87 | 6.34 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 72.95 | 42.03 | 38.05 | -18.39 | -25.24 | -19.29 |
Capital Expenditures CapEx Growth | -8.1 | -5.91 | -6.48 | -8.34 | -21.23 | -13.56 |
Free Cash Flow Free Cash Flow Growth | 64.85 | 36.12 | 31.56 | -26.73 | -46.47 | -32.85 |
Free Cash Flow Growth | 221.84% | 14.43% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -2.75% | -8.10% | 12.21% | -72.55% | -24.00% | -10.03% |
Pretax Margin | -2.10% | -5.55% | 15.84% | -67.83% | -23.69% | -10.83% |
Profit Margin | -2.08% | -5.62% | 15.74% | -67.88% | -23.81% | -10.34% |
FCF Margin | 15.71% | 9.51% | 9.46% | -9.54% | -14.44% | -11.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 23.02 | - | - | - |
Forward PE | 44.75 | 21.25 | 51.38 | 202.04 | 202.04 | 180.12 |
P/FCF Ratio | 29.28 | 26.56 | 37.15 | - | - | - |
PS Ratio | 4.60 | 2.53 | 3.51 | 2.20 | 1.90 | 8.12 |